Intravenous nicotinamide riboside elevates mouse skeletal muscle NAD<sup>+</sup> without impacting respiratory capacity or insulin sensitivity
| Image |  |
|---|---|
| Description | scientific article published on 02 February 2022 |
| Author/s | |
| Publication date | February 2, 2022 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |